Manning & Napier Group's FMS Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 81 shares of Fresenius Medical Care AG (FMS) worth $1,799, representing 0.00% of the portfolio. First purchased in 2013-Q2, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Manning & Napier Group has maintained a strategic position in FMS, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2015, adding 33,480 shares. Largest reduction occurred in Q3 2017, reducing 154,515 shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Fresenius Medical Care (FMS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Fresenius Medical Care (FMS) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -17 | Reduce 17.35% | 81 | $22.21 |
| Q4 2025 | +98 | New Buy | 98 | $23.89 |
| Q3 2017 | -154,515 | Sold Out | 0 | $0.00 |
| Q2 2017 | -125,700 | Reduce 44.86% | 154,515 | $48.32 |
| Q1 2017 | -58,255 | Reduce 17.21% | 280,215 | $42.12 |
| Q3 2016 | +28,410 | Add 9.16% | 338,470 | $43.77 |
| Q2 2016 | -2,500 | Reduce 0.80% | 310,060 | $43.57 |
| Q1 2015 | +33,480 | Add 12.00% | 312,560 | $41.45 |
| Q3 2014 | +5,330 | Add 1.95% | 279,080 | $34.70 |
| Q4 2013 | -6,510 | Reduce 2.32% | 273,750 | $35.58 |
| Q2 2013 | +280,260 | Add 0.00% | 280,260 | $35.27 |
Manning & Napier Group's Fresenius Medical Care Investment FAQs
Manning & Napier Group first purchased Fresenius Medical Care AG (FMS) in Q2 2013, acquiring 280,260 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Fresenius Medical Care AG (FMS) for 20 quarters since Q2 2013.
Manning & Napier Group's largest addition to Fresenius Medical Care AG (FMS) was in Q2 2013, adding 280,260 shares worth $9.88 M.
According to the latest 13F filing for Q1 2026, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 81 shares of Fresenius Medical Care AG (FMS), valued at approximately $1,799.
As of the Q1 2026 filing, Fresenius Medical Care AG (FMS) represents approximately 0.00% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in Fresenius Medical Care AG (FMS) was 338,470 shares, as reported at the end of Q3 2016.